SINGAPORE, May 28, 2018 /PRNewswire/ -- Mundipharma CEO, Raman Singh, has been included in the 2nd Edition of Asia's Greatest Leaders, which is published by AsiaOne and chosen by consumers and industry in a selection process reviewed by PricewaterhouseCoopers.
This follows an awards ceremony held at the Marina Bay Sands, Singapore in January, which was attended by top CEO's, investors, ambassadors, dignitaries, celebrities, and business icons amongst others.
The purpose of this prestigious publication is to celebrate the emergence of Asia as the fastest growing economy. Asia's Greatest Leaders is a platform for recognising leadership excellence in the region.
Mr Singh, who was recently chosen to be a Business Brand Ambassador for the Singapore Tourism Board, joins fellow iconic leaders featured in book such as Alibaba's Jack Ma, Temasek's Madam Ho Ching and Facebook Co-Founder Eduardo Saverin.
This latest accolade follows recent recognition as Medicine Maker's top Asian executive, and number three overall, in 2018 -- the fourth year in succession that Mr Singh has featured among the publications' top 10 business leaders. He was also named among the Top 100 Global CEOs by CEO Magazine in a ceremony in London this year. In addition, Mundipharma's efforts in healthcare innovation were recently acknowledged by winning a Stevie Award this year.
Acknowledging the latest accolade, Mr Singh said, "I am humbled to be included among other Asian leaders and pioneers in this region, which is increasingly becoming the world's growth engine, but where there are still many healthcare challenges to tackle.
"Success in business requires building high-performing ambitious teams and I'm privileged to lead a fantastic group of people. It's nice to be recognized in so many ways, but ultimately the motivation for everybody at Mundipharma -- the number-one value underpinning our culture -- is putting people and patients at the heart of everything we do. This award reflects the culture we've created and the people who embody it."
Mundipharma's independent associated companies are privately owned entities covering the world's pharmaceutical markets. Mundipharma is a prime example of a company that consistently delivers high quality products while standing by the values that represent the company. Our mission is to alleviate the suffering of patients with cancer and non-cancer pain and to substantially improve their quality of life. Mundipharma is dedicated to bringing to patients with severe and debilitating diseases the benefit of novel treatment options in fields such as pain, oncology, oncology supportive care, ophthalmology, respiratory disease and consumer healthcare.
For more information please visit: www.mundipharma.com.sg